<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Embla Medical — Februar 2026]]></title><description><![CDATA[<p dir="auto">Embla Medical Offentliggør Årsrapport for 2025; CEO Fremhæver Solid Fremgang og Strategisk Momentum <a href="https://proinvestor.com/investornyt/1409968/embla-medical-offentliggor-arsrapport-for-2025-ceo-fremhaever-solid-fremgang-og-strategisk-momentum" rel="nofollow ugc">https://proinvestor.com/investornyt/1409968/embla-medical-offentliggor-arsrapport-for-2025-ceo-fremhaever-solid-fremgang-og-strategisk-momentum</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/401354/embla-medical-februar-2026</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 03:11:51 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/401354.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 03 Feb 2026 06:16:34 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Embla Medical — Februar 2026 on Fri, 13 Feb 2026 11:38:48 GMT]]></title><description><![CDATA[<p dir="auto">Embla Medical har netop aflagt regnskab for fjerde kvartal og helårsregnskab. I den anledning er Klaus Sindahl, Emblas Head of Investor Relations, i studiet hos Helge Larsen. De taler om highlights i regnskabet, om uroen fra USA, tilstedeværelsen i Ukraine, emergin markets, konkurrencesituationen, innovation, aktiekursen, væktspotentiale osv. Kort sagt får du et godt indblik i businesscasen. <a href="https://proinvestor.com/boards/131141" rel="nofollow ugc">https://proinvestor.com/boards/131141</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8056474</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8056474</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 13 Feb 2026 11:38:48 GMT</pubDate></item></channel></rss>